Information
-
Trademark
-
90389507
-
Serial Number
90389507
-
Registration Number
6559649
-
International Classifications
-
Filing Date
December 17, 2020
4 years ago
-
Registration Date
November 16, 2021
3 years ago
-
Transaction Date
November 16, 2021
3 years ago
-
Status Date
November 16, 2021
3 years ago
-
Published for Opposition Date
August 31, 2021
3 years ago
-
Location Date
November 16, 2021
3 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
MURRAY, GEORGE WILLIAM
-
Attorney Name
Nazly Aileen Bayramoglu
Law Office Assigned Location Code
N30
-
Owners
Mark Drawing Code
5000
Mark Identification
SPLENDRIS
Case File Statements
- DM0000: The mark consists of the literal element "SPLENDRIS" in stylized font.
- GS0051: Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemico-pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicated Troches, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Medicinal herbal preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases, Pharmaceutical preparations for the treatment of heart rhythm disorders, Synthetic peptides for the treatment of cardiovascular disease; Dietetic substances adapted for medical use, namely, beverages and food in the nature of vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, mineral food-supplements used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes, namely, Pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
- TR0010: The wording "SPLENDRIS" has no meaning in a foreign language.
Case File Event Statements
-
11/16/2021 - 3 years ago
14 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
8/31/2021 - 3 years ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
8/31/2021 - 3 years ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
8/11/2021 - 3 years ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/28/2021 - 3 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
7/22/2021 - 3 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/21/2021 - 3 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
7/21/2021 - 3 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/16/2021 - 3 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/16/2021 - 3 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
6/16/2021 - 3 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/11/2021 - 3 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/26/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
12/21/2020 - 4 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP